MPI-2 Investment Limited Partnership (MPI), managed and operated by MedVenture Partners, Inc., participated in a 190 million Japanese Yen Series A round of Alivas, Inc. along with an Investment Limited Partnership managed and operated by DBJ Capital, Inc..
>>PDF File
